[Diagnosis and therapy of primary hyperparathyreoidism].
Khalil
P N
PN
Abteilung für Endokrine und Viszeralchirurgie, Chirurgische Klinik und Poliklinik, Klinikum Innenstadt der LMU München. philipe.khalil@med.uni-muenchen.de
Hallfeldt
K
K
D000236:Adenoma / Q000097:blood / Q000150:complications; D000328:Adult; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D000069449:Cinacalcet; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis; D015994:Incidence; D019060:Minimally Invasive Surgical Procedures; D009281:Naphthalenes / Q000627:therapeutic use; D010281:Parathyroid Hormone / Q000097:blood; D010282:Parathyroid Neoplasms / Q000097:blood / Q000150:complications; D016105:Parathyroidectomy / Q000379:methods; D015995:Prevalence; D012737:Sex Factors; D020535:Video-Assisted Surgery
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004232:Diuretics; D009281:Naphthalenes; D010281:Parathyroid Hormone; D002118:Calcium; D000069449:Cinacalcet